Used as main image by Phynd in search results and profile page

Kevin P Barton, MD

Hematology, Hematology & Oncology, Internal Medicine, Medical Oncology

Provider Groups

  • Loyola Medicine Physician

  • Loyola Physician Partners

Primary Contact

888-584-7888
Provider Groups
  • Loyola Medicine Physician

  • Loyola Physician Partners

Primary Contact
888-584-7888

Services & Specialties

Areas of Specialization

  • Hematology
  • Hematology & Oncology
  • Internal Medicine
  • Medical Oncology

Clinical Interests

Conditions Treated

  • thrombocytopenia
  • non hodgkin lymphoma
  • leukemia
  • brain neoplasms
  • amyloidosis
  • aplastic anemia
  • monoclonal gammopathy of undetermined significance
  • thrombocytosis
  • Lymphoma

Locations & Contact

Primary Location

Loyola University Medical Center

2160 S First Ave
Maywood , IL 60153

View hours
Tuesday
8:00am - 5:00pm
Monday
8:00am - 5:00pm
Wednesday
8:00am - 5:00pm
Thursday
8:00am - 5:00pm
Friday
8:00am - 5:00pm
Saturday
8:00am - 5:00pm
Sunday
8:00am - 5:00pm
Loyola University Medical Center

Loyola Medicine Burr Ridge

6800 N Frontage Rd
Burr Ridge , IL 60527

Loyola Medicine Burr Ridge

About

I care for patients with a broad range of diseases. These include complex brain tumors, central nervous system lymphomas, systemic lymphomas including post transplants lymphoproliferative disorders, multiple myeloma, amyloidosis, as well as patients with benign hematologic disorders including thrombotic disorders requiring anticoagulation and/or antiplatelet therapy.

Academic Title

Professor

Ages Seen

Adults - Over 65
Adults - 18 to 64

Procedures Performed

  • cancer

Additional Resources

Education & Certifications

Education

Education:
Ohio State University College of Nursing (1982)

Education:
Ohio State University College of Medicine (1986)

Internship:
The University of Chicago Hospitals and Health System (1987)

Residency:
The University of Chicago Hospitals and Health System (1989)

Fellowship:
The University of Chicago Hospitals and Health System (1994)

Board Certifications

Hematology, Hematology, American Board of Internal Medicine Subspecialty (2007)

Provider Groups

Loyola Medicine Physician

Loyola Physician Partners

Provider Ratings

The following ratings and reviews are based on verified feedback collected from independently administered patient experience surveys. The ratings and comments submitted by patients reflect their own views and opinions. Patient identities are withheld to ensure confidentiality and privacy. Learn More >

4.7 out of 5

(156 ratings)

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

47 Reviews

07/29/2024

The best

07/24/2024

This was an exemplary staff!

06/27/2024

He knows a lot about my rare disease

06/19/2024

Dr. Barton isvan excellent physician, i highly respect him and have the upmost confidence in him.

05/23/2024

Dr Barton has been there for me throughout my entire disease…through thick and through thin! Could ask for a better doctor.

05/20/2024

I am concerned that the provider is not using best practices in helping me. He does not read my lab work until I am in the room with him, he doesn't answer questions on the patient portal and doesn't complete visit notes. This last visit he ordered more blood tests to get to the bottom of why my body is acting like it is on an anticoagulant when I am not. I have been to urgent care twice to have minor cuts stitched to stop the bleeding, of the labs he has done some are abnormal. He just ordered more labs and said come back in 4 months. When I asked if I was just supposed to keep bleeding he just walked off, mumbling something. I have asked to switch providers but was told "no".

05/14/2024

He always answers my questions, shows me results of bloodctests on screen, and listens.,

04/25/2024

All good

04/17/2024

I trust him

04/02/2024

Excellent

04/01/2024

Everything went well everybody is great

02/05/2024

Very well explained on my illness

01/24/2024

Outstanding!

01/18/2024

Works well in referring to other specialists and gives assistance in connecting you.

01/17/2024

Dr Barton is the absolute best hematologist and is extremely knowledgeable and knowledgeable and compassionate!!!

01/04/2024

very good

12/27/2023

Dr. Barton and his staff care and are good listeners.

11/29/2023

Sometimes difficult to understand his responses.

11/22/2023

Hard to understand in some ways. Very soft spoke.

11/16/2023

I feel confident that my medical needs are seriously and professionally being addressed.

11/09/2023

All I can say is my Loyola and my doctor are…The Best Of The Best!

11/06/2023

very attentive to answering questions and making sure all my numbers are in line.

11/04/2023

Think he’s a very good Doctor

11/03/2023

I would follow him anywhere

11/02/2023

The best of care

10/22/2023

Dr. Barton is very personable and down-to-earth.

10/12/2023

Dr. Barton has always been very delpfull and concerned.

10/06/2023

Top notch!

10/01/2023

Shows interest and concern

09/27/2023

Very personable and patient.

09/13/2023

Perfect

09/08/2023

Clean facility.

09/04/2023

Very personable and approachable

09/01/2023

Professional and personal approach

08/30/2023

None

08/25/2023

GOOD SERVICE ON TIME

08/19/2023

HIGH LEVEL OF VENUS DOPPLER PROFESSIONALISM!

08/19/2023

Dr. Barton has always been careful and compassionate over 20 years of helping me through my cancer and post treatment journey.

08/03/2023

I’ve been a patient for 14 years. My doctor has been on top of my incurable disease and was able to put me in a complete metabolic remission for 13.5 years.

08/02/2023

doctor knows a lot more

07/29/2023

I have to travel and hour and a half to see this doctor. Well worth the amount of time and travel to have him as one of my doctors!

07/26/2023

Great

07/24/2023

Keep up good work

07/21/2023

I like Dr. Barton a lot, but someone should have noticed that the blood was drawn but somehow got lost enroute to the lab.

07/11/2023

I can tell that he cares about his pacientes a lot

07/05/2023

Always takes the time to discuss your concerns

07/05/2023

Timely with scheduled appointments
Show more

Publications

  • National Trends and Factors Associated with Voluntary Refusal of Glioblastoma Treatment: A Retrospective Review of the National Cancer Database. Strelko, O.; Swanson, J.; Woldt, P.; Frazzetta, J.; Simon, J.; Ng, I.; Baker, M. S.; Barton, K. P.; Thakkar, J. P.; Prabhu, V. C.; Germanwala, A. V.; World neurosurgery
  • Caspase 8 deletion causes infection/inflammation-induced bone marrow failure and MDS-like disease in mice. Liu, S.; Joshi, K.; Zhang, L.; Li, W.; Mack, R.; Runde, A.; Hagen, P. A.; Barton, K.; Breslin, P.; Ji, H. L.; Kini, A. R.; Wang, Z.; Zhang, J.; Cell death & disease
  • Age-stratified comorbid and pharmacologic analysis of patients with glioblastoma. Rabin, E. E.; Huang, J.; Kim, M.; Mozny, A.; Lauing, K. L.; Penco-Campillo, M.; Zhai, L.; Bommi, P.; Mi, X.; Power, E. A.; Prabhu, V. C.; Anderson, D. E.; Barton, K. P.; Walunas, T. L.; Schiltz, G. E.; Amidei, C.; Sanchez-Gomez, P.; Thakkar, J. P.; Lukas, R. V.; Wainwright, D. A.; Brain, behavior, & immunity - health
  • Distinct roles of hematopoietic cytokines in the regulation of leukemia stem cells in murine MLL-AF9 leukemia. Li, Y.; Seet, C. S.; Mack, R.; Joshi, K.; Runde, A. P.; Hagen, P. A.; Barton, K.; Breslin, P.; Kini, A.; Ji, H. L.; Zhang, J.; Stem cell reports
  • MGMT Methylated High Grade Glioma with Distant Recurrence and Stable Original Tumor Site: Case Series. Lee, J.; Lukas, R. V.; Jusue-Torres, I.; Germanwala, A. V.; Borys, E.; Solanki, A. A.; Mallik, A. K.; Barton, K.; Thakkar, J. P.; Annals of hematology & oncology
  • High-risk disease in newly diagnosed multiple myeloma: beyond the R-ISS and IMWG definitions. Hagen, P.; Zhang, J.; Barton, K.; Blood cancer journal
  • COVID-19 thromboembolism incidence, risk factors, and anticoagulation practices from a Chicago metropolitan US population. Berg, S.; Kim, S. H.; Wozniak, A.; Odetola, O.; Arain, S.; Aleem, A.; Coggan, J.; Dave, A.; Elliott, E.; Guerrettaz, R.; Dalal, H.; Lee, R.; Kodali, A.; Moore, P.; Patel, S.; Rajakumar, P.; Qin, S.; Delgado Ramos, G.; Schwartz, C.; Esmail, F.; Feltman Frank, R.; Murchie, E.; Pax, L.; Yun, N.; Zhang, Y.; Barton, K.; Hagen, P.; Hossain, N.; Larson, M. L.; Mai, H.; Nand, S.; Phelan, K.; Venugopal, P.; Stiff, P.; Saraf, S.; American journal of hematology
  • Survival benefit of concomitant chemoradiation in adult supratentorial primary glioblastoma. A propensity score weighted population-based analysis. Jusue-Torres, I.; Hulbert, A.; Barton, K.; Melian, E.; Anderson, D. E.; Quiñones-Hinojosa, A.; Prabhu, V. C.; Journal of neurosurgical sciences
  • Synergistic Therapies for Recurrent Malignant Gliomas. Simon, J. E.; Prabhu, V. C.; Barton, K.; Borys, E.; Piedras-Renteria, E.; Melian, E.; World neurosurgery
  • Value of K i -67 Labeling Index in Predicting Recurrence of WHO Grade I Cranial Base Meningiomas. Matias, J. G.; Jusue-Torres, I.; Martin, B.; Bajaj, A.; Borys, E.; Melian, E.; Barton, K.; Anderson, D. E.; Prabhu, V. C.; Journal of neurological surgery. Part B, Skull base
  • ResearchGate; Quo Vadis? Prabhu, V. C.; Barton, K.; Pappu, S.; Piedras-Renteria, E.; Melian, E.; Biller, J.; World neurosurgery
  • When Monoclonal Gammopathy is of Renal Significance: A Case Study of Crystalglobulinemia From Chicago Multiple Myeloma Rounds. Gilmore, B. A.; Rodby, R. A.; Cimbaluk, D.; Venugopal, P.; Patel, P.; Barton, K.; Hagen, P.; Rodriguez, T.; Sumoza, L.; Bishop, M. R.; Dhakal, B.; Hari, P.; Paner, A.; Clinical lymphoma, myeloma & leukemia
  • Autologous transplantation as consolidation for high risk aggressive T-cell non-Hodgkin lymphoma: a SWOG 9704 intergroup trial subgroup analysis. Al-Mansour, Z.; Li, H.; Cook, J. R.; Constine, L. S.; Couban, S.; Stewart, D. A.; Shea, T. C.; Porcu, P.; Winter, J. N.; Kahl, B. S.; Smith, S. M.; Marcellus, D. C.; Barton, K. P.; Mills, G. M.; LeBlanc, M.; Rimsza, L. M.; Forman, S. J.; Leonard, J. P.; Fisher, R. I.; Friedberg, J. W.; Stiff, P. J.; Leukemia & lymphoma
  • Delayed leptomeningeal metastasis of an adult anaplastic pilocytic astrocytoma. Grahnke, K. A.; Heiferman, D. M.; Borys, E.; Melian, E.; Barton, K. P.; Lukas, R. V.; Shaikh, N.; Leonetti, J. P.; Anderson, D. E.; Brain tumor pathology
  • Cranial Base Meningiomas. Prabhu, V. C.; Melian, E.; Germanwala, A. V.; Solanki, A. A.; Borys, E.; Barton, K.; Anderson, D. E.; World neurosurgery
  • Recurrent Malignant Gliomas: Treatment Options and Their Effect on Patient's Quality of Life. Prabhu, V. C.; Barton, K. P.; Walsh, S.; Borys, E.; Melian, E.; World neurosurgery
  • The role of the Exon 13 G571S JAK2 mutation in myeloproliferative neoplasms. Bahar, B.; Barton, K.; Kini, A. R.; Leukemia research reports
  • Ibritumomab consolidation after 3 cycles of CHOP plus radiotherapy in high-risk limited-stage aggressive B-cell lymphoma: SWOG S0313. Persky, D. O.; Miller, T. P.; Unger, J. M.; Spier, C. M.; Puvvada, S.; Stea, B. D.; Press, O. W.; Constine, L. S.; Barton, K. P.; Friedberg, J. W.; LeBlanc, M.; Fisher, R. I.; Blood
  • Heckathorn disease revisited. Nand, S.; Barton, K.; Schultz, R.; Klein, M.; Kini, A.; Blood
  • Autologous transplantation as consolidation for aggressive non-Hodgkin's lymphoma. Stiff, P. J.; Unger, J. M.; Cook, J. R.; Constine, L. S.; Couban, S.; Stewart, D. A.; Shea, T. C.; Porcu, P.; Winter, J. N.; Kahl, B. S.; Miller, T. P.; Tubbs, R. R.; Marcellus, D.; Friedberg, J. W.; Barton, K. P.; Mills, G. M.; LeBlanc, M.; Rimsza, L. M.; Forman, S. J.; Fisher, R. I.; The New England journal of medicine
  • Management of diffuse low-grade cerebral gliomas. Prabhu, V. C.; Khaldi, A.; Barton, K. P.; Melian, E.; Schneck, M. J.; Primeau, M. J.; Lee, J. M.; Neurologic clinics
  • Hydroxyurea, azacitidine and gemtuzumab ozogamicin therapy in patients with previously untreated non-M3 acute myeloid leukemia and high-risk myelodysplastic syndromes in the elderly: results from a pilot trial. Nand, S.; Godwin, J.; Smith, S.; Barton, K.; Michaelis, L.; Alkan, S.; Veerappan, R.; Rychlik, K.; Germano, E.; Stiff, P.; Leukemia & lymphoma
  • Recurrent strokes in two patients with POEMS syndrome and Castleman's disease. Garcia, T.; Dafer, R.; Hocker, S.; Schneck, M.; Barton, K.; Biller, J.; Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
  • Expanding the pathologic spectrum of immunoglobulin light chain proximal tubulopathy. Kapur, U.; Barton, K.; Fresco, R.; Leehey, D. J.; Picken, M. M.; Archives of pathology & laboratory medicine
  • Management of scalp toxic epidermal necrolysis and cranial osteomyelitis with serratus anterior myocutaneous pedicle flap: a case report. Levitt, M. R.; Benedict, W. J.; Barton, K.; Melian, E.; Gamelli, R. L.; Vandevender, D.; Rosseau, G.; Prabhu, V. C.; Journal of burn care & research : official publication of the American Burn Association
  • Blast crisis in chronic myelogenous leukemia remains a difficult therapeutic challenge. Nand, S.; Barton, K.; Leukemia & lymphoma
  • A unique case of acute promyelocytic leukemia showing monocytic differentiation after ATRA (all-trans retinoic acid) therapy. Naeem, M.; Harrison, K.; Barton, K.; Nand, S.; Alkan, S.; European journal of haematology
  • Overexpression of the NOTCH ligand JAG2 in malignant plasma cells from multiple myeloma patients and cell lines. Houde, C.; Li, Y.; Song, L.; Barton, K.; Zhang, Q.; Godwin, J.; Nand, S.; Toor, A.; Alkan, S.; Smadja, N. V.; Avet-Loiseau, H.; Lima, C. S.; Miele, L.; Coignet, L. J.; Blood